Pretreatment with intracoronary mimosine improves postischemic myocardial functional recovery

Surgery

Volumn 150, Issue 2, 2011, Pages 191-196

  Crowe, Brandon ^b   Poynter, Jeffrey A ^b   Manukyan, Mariuxi C ^b   Wang, Yue ^b   Brewster, Benjamin D ^b   Herrmann, Jeremy L ^b   Abarbanell, Aaron M ^b   Weil, Brent R ^b   Meldrum, Daniel R ^a,b  

^a METHODIST HOSPITAL   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIMOSINE;

ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; INTERMETHOD COMPARISON; LEFT VENTRICULAR DEVELOPED PRESSURE; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAT; REPERFUSION INJURY; TREATMENT RESPONSE;

ANIMALS; CORONARY VESSELS; ENZYME INHIBITORS; HYPOXIA-INDUCIBLE FACTOR 1; INFUSIONS, INTRA-ARTERIAL; MALE; MIMOSINE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79960905862     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.05.009     Document Type: Article

References (23)

1. J.L. Herrmann, A.M. Abarbanell, B.R. Weil, Y. Wang, M. Wang, and J. Tan Cell-based therapy for ischemic heart disease: a clinical update Ann Thorac Surg 88 2009 1714 1722
2. M. Gnecchi, H. He, O.D. Liang, L.G. Melo, F. Morello, and H. Mu Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells Nat Med 11 2005 367 368 (Pubitemid 40562318)
3. H. Haider, S. Jiang, N.M. Idris, and M. Ashraf IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha/CXCR4 signaling to promote myocardial repair Circ Res 103 2008 1300 1308
4. T. Kinnaird, E. Stabile, M.S. Burnett, C.W. Lee, S. Barr, and S. Fuchs Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 2004 678 685 (Pubitemid 38387752)
5. R. Uemura, M. Xu, N. Ahmad, and M. Ashraf Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling Circ Res 98 2006 1414 1421 (Pubitemid 43948066)
6. B. Zeng, X. Ren, G. Lin, C. Zhu, H. Chen, and J. Yin Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement Cell Biol Int 32 2008 1256 1264
7. G.V. Silva, S. Litovsky, J.A. Assad, A.L. Sousa, B.J. Martin, and D. Vela Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model Circulation 111 2005 150 156 (Pubitemid 40139725)
8. E. Chavakis, C. Urbich, and S. Dimmeler Homing and engraftment of progenitor cells: a prerequisite for cell therapy J Mol Cell Cardiol 45 2008 514 522
9. K.W. Liechty, T.C. MacKenzie, A.F. Shaaban, A. Radu, A.M. Moseley, and R. Deans Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep Nat Med 6 2000 1282 1286
10. J.G. Shake, P.J. Gruber, W.A. Baumgartner, G. Senechal, J. Meyers, and J.M. Redmond Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Ann Thorac Surg 2002 731919 731925 discussion 26
11. T.A. Markel, Y. Wang, J.L. Herrmann, P.R. Crisostomo, M. Wang, and N.M. Novotny VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function Am J Physiol Heart Circ Physiol 295 2008 H2308 H2314
12. X. Shen, C. Wan, G. Ramaswamy, M. Mavalli, Y. Wang, and C.L. Duvall Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice J Orthop Res 27 2009 1298 1305
13. P. Hill, D. Shukla, M.G. Tran, J. Aragones, H.T. Cook, and P. Carmeliet Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury J Am Soc Nephrol 19 2008 39 46
14. W. Chen, V. Jadhav, J. Tang, and J.H. Zhang HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model Neurobiol Dis 31 2008 433 441
15. S. Katoh, J. Toyama, I. Kodama, K. Kamiya, T. Akita, and T. Abe Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts Eur Surg Res 24 1992 349 355 (Pubitemid 23054971)
16. J.L. Herrmann, A.M. Abarbanell, B.R. Weil, Y. Wang, J.A. Poynter, and M.C. Manukyan Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function Am J Physiol Regul Integr Comp Physiol 299 2010 R371 R378
17. J.B. Hay, I.G. Maddocks, and S.C. Mills Effect of three depilatory agents; dexamethasone, mimosine and N-[5-(4-aminophenoxy) pentyl] phthalimide on white blood cell counts in sheep Aust Vet J 59 1982 60
18. R. Llano, S. Epstein, R. Zhou, H. Zhang, D. Hamamdzic, and M.G. Keane Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs Catheter Cardiovasc Interv 73 2009 251 257
19. K.G. Shyu, B.W. Wang, H.F. Hung, C.C. Chang, and D.T. Shih Mesenchymal stem cells are superior to angiogenic growth factor genes for improving myocardial performance in the mouse model of acute myocardial infarction J Biomed Sci 13 2006 47 58 (Pubitemid 43162505)
20. B.R. Weil, M.C. Manukyan, J.L. Herrmann, Y. Wang, A.M. Abarbanell, and J.A. Poynter Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia Surgery 148 2010 444 452
21. P. Rameshwar Casting doubt on the safety of "off-the-shelf" mesenchymal stem cells for cell therapy Mol Ther 17 2009 216 218
22. R. Pal, M. Hanwate, and S.M. Totey Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation J Tissue Eng Regen Med 2 2008 436 444
23. J.M. Polak, and S. Mantalaris Stem cells bioprocessing: an important milestone to move regenerative medicine research into the clinical arena Pediatr Res 63 2008 461 466 (Pubitemid 351572213)